2nd Annual Pharma AI Summit

Decoding the Future Trajectory of Pharmaceutical Industry with Artificial Intelligence

8 — 9 April, 2021 Virtual Summit

The event has already occured.

Key facts

Date: 8 — 9 April, 2021

Place: Virtual Summit

Conference Overview

Artificial Intelligence promises vast opportunities for economic and societal benefits in the pharmaceutical industry, lifesciences and healthcare including care delivery with digital health. As data applications supported by AI become more advanced, the whole healthcare value chain has been affected. New forms of drug discoveries and pharma workforces are going to evolve. At the same time, the collection of real-world evidence using AI platforms will alter the role of patients. Among these new technologies, it is important to follow up the developments and discoveries effecting pharmaceutical industry.

This conference provides a comprehensive view of the role that Artificial Intelligence plays, the key challenges and opportunities, as well as the strategic perspective on industry change. In times of disruptive innovation, success is based on a company’s ability to adapt, innovate and collaborate. This event therefore serves as a platform that fosters industry relationships, providing the opportunity for the development of innovative business solutions. We invite you to discuss and debate these challenges in a dialogue amongst top professionals in Pharma and Artificial Intelligence.

Key topics

  • How predictive models generated with AI could be effectively used in pharma?
  • How Artificial Intelligence helps to reach truly data-driven drug discovery?
  • How can advancements in AI and ML tools improve prediction of infectious disease outbreaks? What kinds of innovative public-private partnerships can be used to develop new AI tools? How does the pharma industry invest in the right AI solutions to deliver the right drug?
  • How Real World Evidence can make drug development cheap and more effective?
  • What is the best way to validate Clinical Trial Data with Artificial Intelligence?
  • What are the obstacles in the clinical trials for patients, physicians, IRB/HA, legal, Industry?
  • How AI can help in management, transmission and interpretation of imaging data?
  • How AI can help to interpret genomic variations and their effects on cellular responses? How AI is playing a role in managing medication safety at multiple levels?
  • How AI is used for knowledge sharing based on scope of collaborations and business models?

Who should attend

Medical doctors | Research scientists | Data-scientists | CEOs| CTOs| Managers| Directors Department Heads |Biomedical |Research Engineers specializing  in pharmaceutical: 

  • Artificial Intelligence 
  • Machine-learning 
  • Drug discovery and development 
  • Data-science 
  • Deep-learning 
  • Predictive analytics 
  • Data-analytics 
  • Pre-clinical trials 
  • Clinical trials 
  • Clinical Data Management 
  • Medical imaging 
  • Bio-informatics 
  • Bio-technology 
  • Clinical innovation 
  • Scientific computing 
  • Drug design 
  • Risk Management 
  • Business Development 
  • Patient Support Programs 
  • Computational screening

Event Speakers

Dr. Sherif Fahmy

Chief Innovation Director

Pfizer

Dr. Samiul Hasan

Scientific Analytics and Visualization Director

GlaxoSmithKline

Ritesh Mohan Srivastava

Associate Director - Data Science, Digital and Advanced Analytics

Novartis

Catherine Williams

Senior Director & Privacy Counsel, North America Privacy Office

Novo Nordisk

Haydn Boehm

Head of Commercial Marketing

Merck

Dr. Salvatore G. Cicirello

Senior Director Safety Science and PASS, Worldwide Patient Safety

Celgene

Mark Milton-Edwards

Head of Health Solutions - Digital Health

Teva Pharmaceuticals

Ed Addison

Chairman and CEO

Cloud Pharmaceuticals

Prof. Dr. Vladimir Anisimov

Principal Data Scientist, Data Science, Center for Design & Analysis

Amgen

Dr. Kevin Hua

Senior Manager AI/ML

Bayer

Dr. Ofure Obazee

Quality Strategy Lead (Data Analyst)

Merck Healthcare KGaA

Lars Böhm

Partner – Life Sciences Industry Leader

IBM

Ines de Santiago

Principal Scientist – Computational Biology

e-theraupetics

Pedro Manzione

Director Strategic Analytics & Insights

IQVIA

Georg Turi

Global Director, Head of Health & Life Sciences AI CoE

Cognizant

Dr. Namshik Han

Head of Artificial Intelligence

Milner Therapeutics Institute, University of Cambridge

Dr. Annastasiah M. Mhaka

Founder

Mawambo Lifesciences

Andrey Malyy

Global Head, Digital Innovation & CX

Sanofi

Katya Lobynko

Global Digital Innovation Lead

Sanofi

Dr. Bob Bollinger

Professor of Infectious Diseases, Medicine, Public Health and Nursing and Director

Center for Clinical Global Health

Changrong Ji

Founder

A3.Ai

Jane Reed

Director, Life Sciences

Linguamatics, an IQVIA company

Silver Sponsor

Companies attending the conference

Subscribe to our newsletter

Receive exclusive offers & the latest news on our events and services.